Dr. Shad Marvasti, director of public health, prevention and health promotion with the University of Arizona College of Medicine – Phoenix, is interviewed about how Arizona can better prepare for a new coronavirus surge.

While the days leading up to most presidential elections carry a certain frenzied, exhausted energy fueled by attack ads and nonstop robocalls, this election cycle has felt abnormally anxiety-inducing for many Americans. “We’re certainly in the middle of a perfect storm,” said Dr. Esther Sternberg, research director at the Andrew Weil Center for Integrative Medicine at the University of Arizona. Humans respond physiologically to stress — we sweat, our hearts race — and those responses, Sternberg said, are essential for our survival.

Omitting radiation and giving fewer chemotherapy treatments may become the new standard of care for patients with diffuse large B-cell lymphoma (DLBCL) classified as either stage 1 or 2, according to the findings of the S1001 study led by a University of Arizona Health Sciences researcher.

ENR Southwest’s 2020 Best Projects competition drew 74 entries from across Arizona, Nevada and New Mexico. The University of Arizona Health Sciences Innovation Building (HSIB) was selected in the Best Project category. The region’s 18 Best Projects will now advance to the national level, competing with winners from nine other regions to be considered for ENR’s Best of the Best awards.

Experts in the Comprehensive Pain and Addiction Center are tackling the diverse yet related issues of substance misuse, chronic pain and addiction.

The Mel and Enid Zuckerman College of Public Health turns 20 this year, find out who has worked at the college the entire time.

The College of Public Health honors its ‘MEZCOPH Originals,’ faculty and staff who have been with the college since its inception in 2000.

Health professionals trained to work together can give children with severe pulmonary diseases better, more holistic care.

Continuing coverage: A recent study led by University of Arizona Health Sciences researchers found that COVID-19 antibodies can last between five and seven months after recovery. However, contradictory research suggests that they fade within weeks.